Testis-specific protein Y-encoded 1 regulates androgen receptor expression through the MAPK/ERK pathway in male hepatocellular carcinoma

References

1. 1.↵
   1. Jafri W,
   2. Kamran M.

   Hepatocellular carcinoma in Asia: a challenging situation. Euroasian J Hepatogastroenterol 2019; 9: 27–33.

   OpenUrl
2. 2.↵
   1. McGlynn KA,
   2. Petrick JL,
   3. El-Serag HB.

   Epidemiology of hepatocellular carcinoma. Hepatology 2021; 73: 4–13.

   OpenUrlCrossRef
3. 3.↵
   1. Tu W,
   2. Yang B,
   3. Leng X,
   4. Pei X,
   5. Xu J,
   6. Liu M, et al.

   Testis-specific protein, Y-linked 1 activates PI3K/AKT and RAS signaling pathways through suppressing IGFBP3 expression during tumor progression. Cancer Sci 2019; 110: 1573–1586.

   OpenUrl
4. 4.↵
   1. Leng X,
   2. Liu M,
   3. Tao D,
   4. Yang B,
   5. Zhang Y,
   6. He T, et al.

   Epigenetic modification-dependent androgen receptor occupancy facilitates the ectopic TSPY1 expression in prostate cancer cells. Cancer Sci 2021; 112: 691–702.

   OpenUrl
5. 5.↵
   1. Li S,
   2. Mo C,
   3. Huang S,
   4. Yang S,
   5. Lu Y,
   6. Peng Q, et al.

   Over-expressed testis-specific protein Y-encoded 1 as a novel biomarker for male hepatocellular carcinoma. PLoS One 2014; 9: e89219.

   OpenUrl
6. 6.↵
   1. Li Y,
   2. Xu A,
   3. Jia S,
   4. Huang J.

   Recent advances in the molecular mechanism of gender disparity in hepatocellular carcinoma. Oncol Lett 2019; 17: 4222–4228.

   OpenUrl
7. 7.↵
   1. Guo YJ,
   2. Pan WW,
   3. Liu SB,
   4. Shen ZF,
   5. Xu Y,
   6. Hu LL.

   ERK/MAPK signalling pathway and tumorigenesis. Exp Ther Med 2020; 19: 1997–2007.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Zhang Q,
   2. Cheng S,
   3. Cao L,
   4. Yang J,
   5. Wang Y,
   6. Chen Y.

   LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway. Biosci Rep 2020; 40: BSR20192790.

   OpenUrl
9. 9.
   1. Xing Y,
   2. Liu Y,
   3. Qi Z,
   4. Liu Z,
   5. Wang X,
   6. Zhang H.

   LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway. Cell Mol Biol Lett 2021; 26: 49.

   OpenUrl
10. 10.↵
    1. Fang Z,
    2. Fan R,
    3. Lu Y,
    4. Sun Y,
    5. Zhao C,
    6. Liu L, et al.

    Circular RNA hsa_circ_0002124 promotes hepatocellular carcinoma cell proliferation through the MAPK pathway. Transl Cancer Res 2019; 8: 367–378.

    OpenUrl
11. 11.↵
    1. Oram SW,
    2. Liu XX,
    3. Lee TL,
    4. Chan WY,
    5. Lau YF.

    TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells. BMC Cancer 2006; 6: 154.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Huang WC,
    2. Zhau HE,
    3. Chung LW.

    Androgen receptor survival signaling is blocked by anti-beta2-microglobulin monoclonal antibody via a MAPK/lipogenic pathway in human prostate cancer cells. J Biol Chem 2010; 285: 7947–7956.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Kur P,
    2. Kolasa-Wołosiuk A,
    3. Misiakiewicz-Has K,
    4. Wiszniewska B.

    Gender hormone-dependent physiology and diseases of liver. Int J Environ Res Public Health 2020; 17: 2620.

    OpenUrl
14. 14.
    1. Zheng B,
    2. Zhu YJ,
    3. Wang HY,
    4. Chen L.

    Gender disparity in hepatocellular carcinoma (HCC): multiple underlying mechanisms. Sci China Life Sci 2017; 60: 575–584.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Bashir Hamidu R,
    2. Chalikonda DM,
    3. Hann HW.

    Gender disparity in host responses to hepatitis B-related hepatocellular carcinoma: a case series. Vaccines (Basel) 2021; 9: 838.

    OpenUrl
16. 16.↵
    1. Ao J,
    2. Meng J,
    3. Zhu L,
    4. Nie H,
    5. Yang C,
    6. Li J, et al.

    Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion. Mol Oncol 2012; 6: 507–515.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Moon H,
    2. Ro SW.

    MAPK/ERK signaling pathway in hepatocellular carcinoma. Cancers (Basel) 2021; 13: 3026.

    OpenUrl
18. 18.↵
    1. Cheng Z,
    2. Li X,
    3. Hou S,
    4. Wu Y,
    5. Sun Y,
    6. Liu B.

    K-Ras-ERK1/2 accelerates lung cancer cell development via mediating H3K18ac through the MDM2-GCN5-SIRT7 axis. Pharm Biol 2019; 57: 701–709.

    OpenUrl
19. 19.↵
    1. Tian P,
    2. Zhu Y,
    3. Zhang C,
    4. Guo X,
    5. Zhang P,
    6. Xue H.

    Ras-ERK1/2 signaling contributes to the development of colorectal cancer via regulating H3K9ac. BMC Cancer 2018; 18: 1286.

    OpenUrl
20. 20.↵
    1. Agoulnik IU,
    2. Weigel NL.

    Androgen receptor coactivators and prostate cancer. Adv Exp Med Biol 2008; 617: 245–255.

    OpenUrlCrossRefPubMed
21. 21.
    1. Chen H,
    2. Libertini SJ,
    3. Wang Y,
    4. Kung HJ,
    5. Ghosh P,
    6. Mudryj M.

    ERK regulates calpain 2-induced androgen receptor proteolysis in CWR22 relapsed prostate tumor cell lines. J Biol Chem 2010; 285: 2368–2374.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Wegiel B,
    2. Jiborn T,
    3. Abrahamson M,
    4. Helczynski L,
    5. Otterbein L,
    6. Persson JL, et al.

    Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways. PLoS One 2009; 4: e7953.

    OpenUrlCrossRefPubMed